BioSpace News Archive

Inato, the first global industry marketplace that matches research sites to the right clinical trial protocols, today announced over 500 sites across more than 30 countries are participating in its Marketplace. Sanofi and Merck KGaA, Darmstadt, Germany have also joined the Marketplace, which will further Inato’s mission to accelerate the pace of medical innovation to improve people’s lives.

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for VLX-1005 for the treatment of heparin induced thrombocytopenia (HIT). “We are pleased the FDA has granted Orphan Drug Des

Fact.MR, a global research firm, in its latest research on the future of tuberculosis biomarkers market is anticipated with twofold CAGR in 2021 & beyond.

The modernization of healthcare services in developing countries is anticipated to provide sizeable growth opportunities to the clinical chairs market in the years ahead.

Deep vein thrombosis is the blood clot that develops in the deep veins of the body.

ICP monitoring devices, or intracranial pressure (ICP) monitoring devices, are placed inside the head to monitor the pressure inside the skull and transmit measurements or data to a recording device

Technological progress made in the treatment of ischemic optic neuropathy coupled with the availability of alternative drugs is expected to boost the growth of the global ischemic optic neuropathy treatment market over the period of analysis, from 2020 to 2030.

The pharmaceutical glass ampoules market is expected to gain promising growth across the forecast period of 2020-2030.

Microcaps AG, a developer of formulation, processes and equipment to generate precision microcapsules, announced that it has closed a CHF 5 million seed financing round co-led by Helvetica Capital and Zürcher Kantonalbank.

Fact.MR, a global research firm, in its latest study on the global psychotic disorder treatment market is projected to record a notable CAGR in 2021 & beyond.